Holocene Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-105,543
Closed -$31.7M 802
2024
Q4
$31.7M Sell
105,543
-201,253
-66% -$70.3M 0.1% 213
2024
Q3
$125M Buy
306,796
+208,015
+211% +$76.2M 0.5% 58
2024
Q2
$31.7M Sell
98,781
-141,473
-59% -$46M 0.13% 174
2024
Q1
$80.1M Sell
240,254
-181,888
-43% -$55.6M 0.29% 107
2023
Q4
$114M Buy
422,142
+413,807
+4,965% +$102M 0.45% 77
2023
Q3
$2.05M Buy
+8,335
New +$2.28M 0.01% 559
2023
Q2
Sell
-15,261
Closed -$4.02M 774
2023
Q1
$4.02M Sell
15,261
-83,317
-85% -$21.2M 0.02% 324
2022
Q4
$23.7M Sell
98,578
-121,740
-55% -$27.3M 0.14% 166
2022
Q3
$40.5M Buy
+220,318
New +$43.9M 0.26% 119
2020
Q2
Sell
-206,996
Closed -$18.6M 678
2020
Q1
$18.6M Sell
206,996
-107,798
-34% -$14M 0.2% 127
2019
Q4
$46.5M Sell
314,794
-41,335
-12% -$5.55M 0.42% 79
2019
Q3
$42.9M Buy
356,129
+121,472
+52% +$15.7M 0.44% 74
2019
Q2
$31.7M Buy
+234,657
New +$29.7M 0.4% 84

Other funds holding HCA

Holocene Advisors's HCA Position: Q1 2025 in Review

Holocene Advisors sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 105,543 shares — an estimated $31.7M sold.

Holocene Advisors first reported a position in HCA in Q2 2019 and held it in 13 quarters. The position peaked at $125M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Holocene Advisors reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Holocene Advisors sold 105,543 HCA Healthcare shares in Q1 2025, an estimated $31.7M.
  • Holocene Advisors first reported a position in HCA Healthcare in Q2 2019 and held it in 13 quarters.
  • Holocene Advisors's HCA Healthcare position peaked at $125M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Holocene Advisors's 13F filing for Q1 2025, filed 15 May 2025.